By PPH Foundation
Postpartum haemorrhage (PPH), or excessive bleeding after childbirth, is usually discussed in relation to complications such as the uterus failing to contract, retained placental tissue or injury to the birth canal. But there is another, less familiar pathway to severe bleeding: a venomous snakebite during pregnancy can interfere with the body’s ability to form blood clots, placing a woman at risk of life-threatening haemorrhage during delivery or after birth.
The connection is uncommon, but it is clinically important, particularly in regions where people live or work close to snake habitats and where access to emergency care may be delayed. Snakebite is a recognised medical emergency. During pregnancy, its effects can threaten both the woman and her unborn baby, with complications ranging from bleeding disorders and kidney injury to premature labour, placental complications and fetal distress. The severity depends on the snake species, the amount and type of venom injected, and how quickly the woman receives appropriate treatment. Not every snakebite involves venom, and not every venomous bite causes systemic complications. However, when venom affects the clotting system, the consequences can be serious. (World Health Organization [WHO], 2026).
A case reported in Kenya illustrates how quickly this danger can unfold. Published in the East African Medical Journal in November 2025, the report describes a woman at 38 weeks of pregnancy who was bitten on the leg. She subsequently went into spontaneous, rapid labour and delivered a live infant. After delivery, she developed massive PPH associated with disseminated intravascular coagulation, a serious disorder in which the body’s clotting system becomes dangerously disrupted. The woman required emergency treatment, including blood transfusion and other measures to support her circulation and control the bleeding. The authors highlighted the diagnostic and treatment challenges of managing snakebite during pregnancy in a resource-limited setting. (Wambaya et al., 2025).
To understand how a snakebite can lead to PPH, it is important to look at what happens when venom enters the bloodstream. Some venomous snakes, including certain vipers, have toxins that affect blood vessels, platelets and the proteins responsible for clotting. One recognised complication is venom-induced consumption coagulopathy, commonly known as VICC. In this condition, venom activates parts of the clotting system in an abnormal way, causing clotting factors to be consumed. As these essential components become depleted, the blood may lose its ability to clot effectively. A woman may then experience bleeding from the bite site, gums, nose, internal organs or other parts of the body. Severe bleeding can occur even when the external wound appears small. (Gutiérrez et al., 2025).
The risk becomes especially concerning around childbirth. Delivery involves the separation of the placenta from the uterus, leaving blood vessels that must close through uterine contraction and the body’s clotting mechanisms. If a woman’s clotting factors have been depleted by venom, she may struggle to control bleeding. This does not mean that snake venom directly causes every case of PPH. Rather, venom-related coagulopathy can make bleeding more severe or difficult to stop when an obstetric haemorrhage occurs.
In some cases, the clotting disturbance may progress to disseminated intravascular coagulation, or DIC. This is a complex and potentially life-threatening condition in which widespread clotting activation consumes platelets and clotting factors. The woman may develop both abnormal clot formation and severe bleeding. DIC can occur in different obstetric emergencies, and snakebite envenoming is one possible trigger. When it develops during or after delivery, it can complicate the management of PPH and increase the need for urgent blood products and specialist care.
The connection is not only theoretical. A 2026 case report from Ecuador described a woman at 40 weeks and six days of pregnancy who was bitten by a Bothrops snake. She developed a clotting abnormality and received antivenom. Because of fetal distress and low amniotic fluid, an urgent caesarean section was performed. After delivery, she developed severe PPH associated with venom-induced coagulopathy and uterine atony. Her treatment included further antivenom, intensive care and ultimately a subtotal hysterectomy. The report illustrates how venom-related clotting problems and an obstetric cause of bleeding can occur together. (Loza-Hernandez et al., 2026).
Snakebite during pregnancy can also affect the baby. Severe maternal bleeding, shock or placental complications may reduce the oxygen supply to the fetus. Venom-related illness may be associated with fetal distress, premature labour or pregnancy loss. A 2026 case report from Cameroon described prolonged coagulopathy following snakebite during pregnancy in a resource-constrained setting, further demonstrating the challenges of managing envenoming when specialist treatment and monitoring may be difficult to access. These reports do not establish the overall frequency of such outcomes, but they underline the need to treat snakebite in pregnancy as an emergency requiring careful assessment of both mother and fetus. (Ngman-Wara et al., 2026).
The first priority after a suspected snakebite is rapid transfer to a health facility. The woman should not wait for bleeding, swelling or other symptoms to appear. WHO advises that people suspected of being bitten by a venomous snake be transported to a facility capable of assessing and treating envenoming without delay. Antivenom is the specific treatment that can prevent or reverse many effects of venom when the correct product is given promptly and appropriately. The decision to administer it should be made by trained clinicians based on the clinical presentation and evidence of envenoming. Pregnancy should not be a reason to delay urgent treatment. (WHO, 2026).
In hospital, care may include close monitoring of the woman’s vital signs, assessment of clotting function, blood counts and kidney function, and evaluation of fetal wellbeing. If bleeding develops, the team may need to manage both the obstetric cause of haemorrhage and the underlying clotting disorder. This may require antivenom, blood and blood products, medicines to support uterine contraction, and other emergency interventions. Coordinated care involving emergency clinicians, obstetricians, laboratory teams, anaesthesia and blood transfusion services is essential.
For maternal health professionals, the lesson is that a woman who has been bitten by a snake during pregnancy may face risks that extend beyond the bite wound. A history of snakebite should be considered when assessing unexplained bleeding, abnormal clotting results, sudden deterioration or severe haemorrhage during labour and after delivery—particularly in areas where venomous snakebites occur.
For communities, the message is equally important: snakebite during pregnancy requires urgent medical attention. Traditional remedies, cutting or sucking the wound, and applying a tight tourniquet can delay appropriate treatment or cause further harm. The woman should be kept as still as possible and transported to a health facility immediately.
PPH is a multifactorial emergency, and snakebite is not among its common causes. Yet the documented cases show that venom-induced coagulopathy can become a dangerous contributor to bleeding around childbirth. Recognising this link can help clinicians anticipate complications, support timely referral and prepare for the possibility of severe haemorrhage.
Preventing maternal deaths requires attention to both familiar obstetric emergencies and less recognised threats. When a venomous snakebite disrupts the body’s ability to clot, the emergency may not end when the bite is treated. For a pregnant woman, the danger can continue into labour and the hours after birth—when rapid, coordinated care can make the difference between survival and a devastating outcome.
References
Gutiérrez, J. M., et al. (2025). Haemotoxicity of snakes: A review of pathogenesis, clinical manifestations, novel diagnostics and challenges in management. Transactions of the Royal Society of Tropical Medicine and Hygiene, 119(3), 283–303. https://doi.org/10.1093/trstmh/trae058
Loza-Hernandez, F., Haro, A., Carrión, G., & Loza, H. (2026). A case report of postpartum hemorrhage secondary to snake bite envenomation: A pathogenesis and current management review. Case Reports in Obstetrics and Gynecology, 2026, 1956143. https://doi.org/10.1155/crog/1956143
Ngman-Wara, G. M., Balegha, A. N., Maroun, Z. S., et al. (2026). Management of snakebite envenomation in pregnancy with prolonged coagulopathy in a resource-constrained setting: A case report. BMC Pregnancy and Childbirth. https://doi.org/10.1186/s12884-026-09980-8
Wambaya, D. S., Jerotich, K. G., Rosalba, L., & Vincent, E. (2025). The venomous delivery: A case report of snake bite in pregnancy with precipitate labour and disseminated intravascular coagulation managed in a low resource setting. East African Medical Journal, 102. https://eamj.co.ke/index.php/eamj/article/download/17/8
World Health Organization. (2026, September 17). Snakebite envenoming. https://www.who.int/news-room/fact-sheets/detail/snakebite-envenoming
World Health Organization. Snakebite envenoming: Treatment. https://www.who.int/teams/control-of-neglected-tropical-diseases/snakebite-envenoming/treatment
Image by kuritafsheen77 on Magnific</a>